Molecular Insight Pharmaceuticals, Inc. to Present at Rodman and Renshaw 11th Annual Healthcare Conference
September 04 2009 - 10:12AM
Marketwired
Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) will make a
presentation at the Rodman and Renshaw 11th Annual Healthcare
Conference on September 10, 2009 at 2 PM, Eastern Daylight Time.
Daniel L. Peters, President and Chief Executive Officer, will
present an overview of the Company and its pipeline of targeted
therapeutic and molecular imaging radiopharmaceuticals. The
presentation will take place in the Fahnestock Salon, on the fifth
floor of the New York Palace Hotel in New York, New York.
The presentation will be webcast live at
http://www.wsw.com/webcast/rrshq15/mipi and will be archived for 90
days. The webcast also will be available in the Investor Relations
section of the Molecular Insight Pharmaceuticals website at
www.molecularinsight.com.
About Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals is a clinical-stage
biopharmaceutical company and a pioneer in the emerging field of
molecular medicine. The Company is focused on the discovery and
development of therapeutic radiopharmaceuticals and targeted
molecular imaging in oncology and cardiology. Molecular Insight has
five clinical-stage candidates in development. The Company's
oncology candidates include: Azedra(TM) for treatment of
pheochromocytoma and neuroblastoma, Onalta(TM) for the treatment of
metastatic carcinoid and pancreatic neuroendocrine tumors,
Solazed(TM), which targets malignant metastatic melanoma, and
Trofex for the detection of metastatic prostate cancer. Zemiva(TM)
is being developed for the diagnosis of acute myocardial ischemia.
For further information on Molecular Insight Pharmaceuticals,
please visit www.molecularinsight.com.
Contact: Investors Deborah S. Lorenz Senior Director Investor
Relations and Corporate Communications (617) 871-6667
dlorenz@molecularinsight.com Media Martin A. Reynolds Manager
Corporate Communications (617) 871-6734
mreynolds@molecularinsight.com
Molecular Insight Pharmaceuticals (MM) (NASDAQ:MIPI)
Historical Stock Chart
From May 2024 to Jun 2024
Molecular Insight Pharmaceuticals (MM) (NASDAQ:MIPI)
Historical Stock Chart
From Jun 2023 to Jun 2024